The Plateau and Release Pattern

In chronic cannabis users during abstinence, THC-COOH concentrations do not decline smoothly. Instead, levels can plateau, decline, and then rise again without any new cannabis use. This phenomenon is particularly consequential for probationers, parolees, and people in recovery who may be accused of relapsing based on an unexpected positive test.

The Central Finding

A person who has genuinely stopped using cannabis can test negative, then test positive days later, with no new use. This is not cheating and it is not re-exposure — it is the direct biological consequence of how THC is stored in and released from fat tissue.

What the Research Shows

The landmark study on this phenomenon is Lowe et al. (2009), published in Drug and Alcohol Dependence:

Lowe RH, Abraham TT, Darwin WD, Herning R, Cadet JL, Huestis MA. "Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure." Drug and Alcohol Dependence 2009;105(1-2):24-32.. PMID: 19631478

The researchers monitored chronic cannabis users under controlled conditions during verified abstinence. They found:

THC-COOH excretion was highly variable across days
Concentrations rose after initial declines in a significant fraction of subjects
In 40% of subjects, the maximum creatinine-normalized THC-COOH concentration occurred 2.9 days after admission to the monitored unit — not on day 1
A previously "negative" test could become "positive" again with no new drug exposure

The title of the paper is notable: the authors explicitly concluded that extended urinary THC-COOH excretion "precludes use as a biomarker of new drug exposure" in chronic users. In other words: a positive test in a chronic user in recovery does not prove they have used again.

Why This Happens

The biological explanation is straightforward once you understand how THC is stored. During active use, THC accumulates in fat tissue throughout the body. Different fat depots (subcutaneous, visceral, intramuscular) release THC back into circulation at different rates. Physical activity, stress, fasting, temperature changes, and hormone fluctuations can all trigger lipolysis (fat breakdown), which releases stored THC.

When stored THC re-enters the bloodstream, the liver metabolizes it to THC-COOH, which is then excreted in urine. If release is uneven — and it typically is — the urinary concentration of THC-COOH fluctuates accordingly. A day with substantial fat mobilization produces a spike in urinary THC-COOH; a day with minimal mobilization produces a trough.

Add creatinine normalization (which corrects for hydration but introduces its own variability) and the picture becomes genuinely noisy. A single negative test does not mean all the THC has left the body. A subsequent positive does not mean new use.

Who Is Most Affected

Chronic heavy users — the larger the body burden, the longer and more variable the release pattern
Higher body-fat individuals — more storage capacity means more to release
People who exercise vigorously during early abstinence — lipolysis mobilizes stored THC
People undergoing weight loss — similar mechanism
People with significant stress — cortisol-driven lipolysis contributes

The Real-World Consequences

Probation and Parole

This is where plateau-and-release causes the most harm. A probationer who has genuinely abstained for a week may test positive on day 5 even after testing negative on day 3. Without understanding of the underlying pharmacology, this looks like relapse — and technical violations can mean jail. Some states have modified their probation testing specifically because of the chronic user detection problem. See Probation & Parole.

Recovery and Treatment

Substance use treatment programs increasingly use drug testing as part of their therapeutic model. A person in recovery from cannabis use disorder who experiences an "unexpected" positive during early abstinence may be wrongly accused of lying about their use — which undermines the therapeutic relationship and can trigger consequences like program expulsion.

Employment Monitoring

Some employers use periodic or random testing as a condition of return-to-work after a positive test. Chronic users can genuinely abstain and still test positive weeks later due to continued fat release.

Child Custody

A parent in a custody dispute who tests negative at an initial hearing and positive at a follow-up hearing may be accused of new use by opposing counsel — when the reality is ongoing release of previously stored THC. See Child Custody.

What Can Be Done

Short of switching to a test that measures current impairment (which most jurisdictions have not done), the most honest mitigation is:

Documentation. If you are in a monitored abstinence situation, testing frequently and keeping careful records can establish a downward trend that contextualizes any spikes.
Creatinine normalization. Raw THC-COOH levels are noisy; creatinine-adjusted levels (THC-COOH/creatinine ratio) are more stable and are increasingly used in research and forensic contexts.
Legal and expert testimony. In high-stakes proceedings (probation violations, custody disputes), expert pharmacology testimony about plateau-and-release can be decisive. The Lowe 2009 paper is the go-to citation.
Awareness. Simply knowing this phenomenon exists can help the person facing testing prepare to explain a surprise positive to their supervisor, treatment provider, or attorney.

A caution about advocacy

Plateau-and-release is real and important, but it is also occasionally invoked to excuse genuine relapses. Chronic use produces weeks-long detection windows, but if you have been abstinent for 60+ days and test positive, the explanation is more likely new use than residual fat release. The science is a shield against false accusations, not a universal defense.